SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,187 | -90.6% | 4,953 | -87.5% | 0.00% | -100.0% |
| Q1 2023 | $183,100 | +19.7% | 39,632 | +35.3% | 0.00% | 0.0% |
| Q2 2022 | $153,000 | +2.0% | 29,298 | +190.3% | 0.00% | 0.0% |
| Q4 2021 | $150,000 | -47.4% | 10,092 | -34.2% | 0.00% | -66.7% |
| Q2 2021 | $285,000 | +9.2% | 15,339 | +34.0% | 0.00% | -25.0% |
| Q1 2021 | $261,000 | – | 11,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
| Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
| First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
| Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
| Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
| Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
| BVF INC/IL | 826,825 | $15,371,000 | 0.58% |